Recently, Chalishazar et al. observed that MYC-driven small-cell lung cancer (SCLC) preferentially depends on arginine-regulated pathways, including polyamine biosynthesis and mTOR pathway activation [44]. The gene discussed is MTOR; the disease is small cell lung carcinoma.